Lack of IRF6 Disrupts Human Epithelial Homeostasis by Altering Colony Morphology, Migration Pattern, and Differentiation Potential of Keratinocytes. by Girousi, Eleftheria et al.
fcell-09-718066 September 28, 2021 Time: 15:28 # 1
ORIGINAL RESEARCH





Morphogenesis, Institute of Animal
Physiology and Genetics, Czech











This article was submitted to
Cell Growth and Division,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 31 May 2021
Accepted: 16 August 2021
Published: 30 September 2021
Citation:
Girousi E, Muerner L, Parisi L,
Rihs S, von Gunten S, Katsaros C and
Degen M (2021) Lack of IRF6 Disrupts
Human Epithelial Homeostasis by
Altering Colony Morphology, Migration
Pattern, and Differentiation Potential
of Keratinocytes.
Front. Cell Dev. Biol. 9:718066.
doi: 10.3389/fcell.2021.718066
Lack of IRF6 Disrupts Human
Epithelial Homeostasis by Altering
Colony Morphology, Migration
Pattern, and Differentiation Potential
of Keratinocytes
Eleftheria Girousi1, Lukas Muerner2, Ludovica Parisi1, Silvia Rihs1, Stephan von Gunten2,
Christos Katsaros1 and Martin Degen1*
1 Laboratory for Oral Molecular Biology, Dental Research Center, Department of Orthodontics and Dentofacial Orthopedics,
University of Bern, Bern, Switzerland, 2 Institute of Pharmacology, University of Bern, Bern, Switzerland
Variants within the gene encoding for the transcription factor Interferon Regulatory
Factor 6 (IRF6) are associated with syndromic and non-syndromic Cleft Lip/Palate (CLP)
cases. IRF6 plays a vital role in the regulation of the proliferation/differentiation balance
in keratinocytes and is involved in wound healing and migration. Since a fraction of CLP
patients undergoing corrective cleft surgery experience wound healing complications,
IRF6 represents an interesting candidate gene linking the two processes. However, Irf6
function has been mainly studied in mice and knowledge on IRF6 in human cells remains
sparse. Here, we aimed to elucidate the role of IRF6 in human postnatal skin- and oral
mucosa-derived keratinocytes. To do so, we applied CRISPR/Cas9 to ablate IRF6 in two
TERT-immortalized keratinocyte cultures, which we used as model cell lines. We show
that IRF6 controls the appearance of single cells and colonies, with the latter being less
cohesive in its absence. Consequently, IRF6 knockout keratinocytes often moved as
single cells instead of a collective epithelial sheet migration but maintained their epithelial
character. Lack of IRF6 triggered severe keratinocyte differentiation defects, which were
already apparent in the stratum spinosum and extended to the stratum corneum in
3D organotypic skin cultures, while it did not alter their growth rate. Finally, proteomics
revealed that most of the differentially expressed proteins in the absence of IRF6 could
be associated with differentiation, cell-cell adhesion as well as immune response. Our
data expand the knowledge on IRF6 in human postnatal keratinocytes, which will help
to better understand IRF6-related pathologies.
Keywords: IRF6, oral mucosa, skin, differentiation, wound healing, proteomics, GRHL3
INTRODUCTION
Interferon regulatory factor 6 (IRF6) belongs to a family of nine transcription factors that mediate
the expression of interferon following viral infections (Yanai et al., 2012). In contrast to the other
family members, which are strictly involved in innate and adaptive immune processes (Ikushima
et al., 2013), IRF6 has been found to be essential for proper craniofacial morphogenesis and skin
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homeostasis (Ingraham et al., 2006). In humans, rare IRF6
variants are causal for Van der Woude syndrome (VWS, OMIM:
119300) and Popliteal Pterygium syndrome (PPS, OMIM:
119500), which are characterized by the presence of orofacial
clefts, lip pits as well as cutaneous and limb defects. In addition,
IRF6 variants have also been found associated with isolated, non-
syndromic orofacial clefts (Kondo et al., 2002; Zucchero et al.,
2004; Leslie et al., 2013).
Mouse models, such as a total Irf6 knockout (Ingraham
et al., 2006) as well as a mouse harboring an Irf6R84C/R84C
variant (Richardson et al., 2006), have been pivotal in the
understanding of IRF6 function. Irf6 disruption in mice results
in perinatal lethality associated with severe skin, limb, and
craniofacial anomalies (Ingraham et al., 2006). In accordance
with these observations and the clinical VWS/PPS phenotypes,
Irf6 was found to be broadly expressed in embryonic and adult
murine tissues with highest levels in the fusing palatal shelves,
hair follicles, palatal rugae, tooth germs and thyroglossal duct,
external genitalia, and skin (Kondo et al., 2002; Knight et al.,
2006). The main role of IRF6 has been attributed to its function
as a master regulator of the balance between keratinocyte
proliferation and differentiation. Indeed, Irf6 knockout mice
exhibit a hyperproliferative epidermis with aberrant localization
of proliferating keratinocytes in the suprabasal spinous cell layer.
Concomitantly, epidermal keratinocytes fail to undergo terminal
differentiation and lack a functional periderm, a second cell
layer that covers the embryonic epithelia and protects them
from pathological adhesions (Ingraham et al., 2006; Richardson
et al., 2006, 2014; Hammond et al., 2019). Such premature
oral adhesions are believed to hinder palatal shelf elevation
during palatogenesis, resulting in orofacial clefts (Richardson
et al., 2014). All these seminal findings in animal models
were more recently complemented and extended by elucidating
the intrinsic cellular behavior of embryonic murine Irf6−/−
keratinocytes in vitro. Similar to the in vivo situation, the
balance between keratinocyte proliferation and differentiation
was found to be altered in Irf6−/− keratinocytes, as they lack
the capacity to terminally differentiate and display an increased
long-term proliferative potential compared to their wildtype (wt)
counterparts (Biggs et al., 2012). Notably, lack of Irf6 also resulted
in an abnormal keratinocyte appearance in vitro with many cells
being larger than controls and presenting with an increased
network of stress fibers (Biggs et al., 2012, 2014).
Successful cutaneous wound healing depends on a well-
orchestrated series of cellular events such as proliferation,
migration, and differentiation leading to the repair of tissue
damage (Shaw and Martin, 2009). Similar cellular processes are
also required for the morphogenesis of the secondary palate
during embryogenesis (Bush and Jiang, 2012; Lan et al., 2015).
Therefore, it has been hypothesized that palatogenesis and wound
healing share common genes and pathways for their distinct, but
similar accomplishment of closing a tissue gap and forming a
seal (Biggs et al., 2015). IRF6 might represent such a candidate
gene. Indeed, particular wound healing defects like reduced
speed and directionality during wound re-epithelialization, as
well as impaired maturation of the granulation tissue, have
been described in embryonic Irf6−/− keratinocytes in vitro
(Biggs et al., 2014) and in Irf6+/− mice in vivo (Rhea et al.,
2020), respectively. These observations might also provide the
molecular rationale for the increased likelihood of wound
healing complications experienced by VWS patients harboring
IRF6 variants in comparison to non-syndromic cleft patients
(Jones et al., 2010).
In the last decades, considerable knowledge has been gained
about IRF6 function during craniofacial development, mostly
using either in vivo animal models or embryonic keratinocytes,
derived from Irf6−/− mice. Still, only a handful of transcriptional
targets of IRF6, such as GRHL3, OVOL1 and KLF4, have been
identified and described so far (Botti et al., 2011; de la Garza
et al., 2013; Liu et al., 2016). Although a role for IRF6 in murine
keratinocyte migration and embryonic wound healing has been
reported, little is known about IRF6 function in postnatal tissue
repair in human cells. Since epithelial-specific differences in
wound healing have been established and described (Eming et al.,
2014; Turabelidze et al., 2014), we sought to decipher the role
of IRF6 in human postnatal keratinocytes isolated from two
different sources: oral mucosa and foreskin.
We used a CRISPR/Cas9 approach to generate IRF6 knockout
keratinocytes derived from postnatal oral mucosa and skin
tissue, which allowed us to study IRF6 function in two distinct
and relevant tissue contexts. We supplemented this approach
with a proteomic analysis to discover novel potential targets or
interactors of IRF6. While our data confirm certain previous
findings in murine models, there are some differences, which
might be specific to human cells. In addition, we also reveal
that all the phenotypes in response to IRF6 ablation were
present in skin- and oral mucosa-derived keratinocytes, although
proteomics reported significantly less changes in the absence
of IRF6 in oral mucosal keratinocytes. Our study substantially
expands the knowledge of IRF6 function in postnatal human
keratinocytes and will be important for a better understanding




Foreskin tissue samples were obtained from two to five years
old healthy boys during routine circumcision at the Children’s
Hospital, University of Bern. Oral mucosa samples were received
from non-syndromic (no mutation within IRF6) CLP patients at
the age of 3-6 months during corrective surgery to close the cleft
lip. From one CLP patient, we were able to get both oral mucosa
as well as skin tissue.
Primary keratinocytes were isolated from the tissue samples
using the explant culture system as described elsewhere (Degen
et al., 2018). After their outgrowth, keratinocytes were purified
from contaminating fibroblasts by differential trypsinization,
followed by their expansion in keratinocyte serum-free
medium (KSFM, Gibco, Thermo Fisher Scientific, Lucerne,
Switzerland) supplemented with 25 µg/ml bovine pituitary
extract, 0.2 ng/ml epidermal growth factor (EGF), and CaCl2 to
a final Ca2+ concentration of 0.4 mM, as previously described
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(Degen et al., 2013; Parisi et al., 2021). All experiments using
primary cells have been performed with cultures from the second
to the fourth passage.
Cell Culture and Treatments
The immortalized oral mucosal keratinocytes OKF6/TERT2
(derived from the floor of the mouth) as well as the immortalized
foreskin-derived strain N/TERT1 keratinocytes (Dickson et al.,
2000) were cultured in complete KSFM.
For growth factor treatments, keratinocytes were grown to
60% confluency followed by addition of EGF (Thermo Fisher
Scientific), Transforming Growth Factor β1 and β3 (TGFβ1,
TGFβ3, PeproTech, London, United Kingdom) at the indicated
concentrations and times before harvesting either RNA or
protein samples.
Immunoblotting
Whole protein lysates from cells were prepared in RIPA
buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 0.1%
sodium deoxycholate, 0.1% SDS, 1% NP40, 140 mM NaCl)
supplemented with cOmplete MiniTM Protease Inhibitor cocktail
and PhosSTOP EASYpack (both from Sigma-Aldrich, St. Louis,
MO, United States). The BCA Protein Assay Kit (Pierce, Thermo
Fisher Scientific) was used to measure protein concentrations
of the samples. Approximately 20 µg of protein were mixed
with loading buffer (2% SDS, 62.6 mM Tris-HCl, pH 6.8,
10% glycerol, 0.01% bromophenol blue) containing 100 mM
dithiothreitol (DTT), boiled for 5 min at 95◦C, fractionated
by SDS-PAGE under reducing conditions and transferred to
nitrocellulose membranes (Sigma-Aldrich). The membranes
were then stained with 0.1% amido black solution (MERCK,
Schaffhausen, Switzerland) to assess blotting efficiency and equal
protein loading. After extensive washing, the membranes were
blocked for 1 h at room temperature (RT) in 5% skim milk
powder (Sigma-Aldrich) dissolved in Tris-buffered saline (pH
7.4) with 0.05% Tween (TBS-Tween), and then incubated with
primary antibodies overnight at 4◦C. Blots were washed three
times in TBS-Tween followed by incubation with horseradish
peroxidase-conjugated anti-mouse/rabbit IgG (Thermo Fisher
Scientific) for 1 h at RT. After three more washes in TBS-Tween,
blots were developed using SuperSignal West Dura or West Pico
(Thermo Fisher Scientific) and scanned by an Imager Chemi
Premium Imager Instrument (VWR, Darmstadt, Germany).
Primary antibodies used for immunoblots: Rabbit polyclonal
antibodies anti-Fibronectin (Wehrle-Haller et al., 1991),
anti-E-Cadherin (20874-1-AP, Proteintech, Manchester,
United Kingdom), anti-TGM1 (Thermo Fisher Scientific),
and anti-GRHL3 (ARP39489_T100; Aviva Systems Biology,
San Diego, CA, United States). Mouse monoclonal antibodies
anti-IRF6 (14B2C16, BioLegend, San Diego, CA, United States),
anti-Involucrin (SY5, BIO-RAD, Hercules, CA, United States),
anti-Vinculin (V9131, Sigma-Aldrich).
Some of the immunoblots were densitometrically analyzed
using the ImageJ software1. Briefly, the intensity of each protein
1https://imagej.nih.gov/ij/
band was normalized to the vinculin band intensity of the same
extract in the same experiment.
Immunofluorescence
For immunofluorescent staining, keratinocytes were cultured
in 35 mm dishes containing four separate wells (Greiner
Bio-One, Frickenhausen, Germany). Cells were washed twice
with phosphate-buffered saline (PBS) before fixation in 4%
paraformaldehyde (PFA) for 20 min at RT. Fixation was
followed by three washing steps in PBS, permeabilization in 0.1%
Triton-X-100 for 5 min, and incubation with primary antibody
for 2 h at RT in PBS/3% bovine serum albumin. Afterward,
keratinocytes were extensively washed with PBS and incubated
with fluorescent-labeled secondary goat anti-mouse/rabbit
IgG (Molecular Probes, Thermo Fisher Scientific) and/or
tetramethylrhodamine (TRITC)-phalloidin (Sigma-Aldrich)
for 1 h in the dark. Finally, cells were washed three times
with PBS and once with H2O before being coverslip-mounted
with Vectashield Mounting Medium containing DAPI (Vector
Laboratories, Burlingame, CA, USA).
Analysis was performed using an Olympus BX-51
phase/fluorescence microscope (OlympusLife Science Solutions,
Tokyo, Japan) equipped with a xenon lamp (X-Cite, series
120PC Q, Lumen Dynamics, Mississauga, Canada). Images were
captured by a ProgRes CT3 camera with ProgRes CapturePro
software (Jenaoptik, Jena, Germany), using a 20x/0.5 objective.
Primary antibodies used for immunofluorescent
staining: Rabbit polyclonal antibodies anti-IRF6 (NBP2-
49383, Novus Biologicals, Centennial, CO, United States),
anti-E-Cadherin (20874-1-AP, Proteintech), anti-TGM1
(NBP2-34062, Novus Biologicals), and anti-Loricrin (PA5-
30583, Thermo Fisher Scientific). Mouse monoclonal antibody
anti-Involucrin (SY5, BIO-RAD).
Proteomic Analysis
Keratinocytes were grown to high density before protein
extraction in 8M urea/100 mM Tris. Reduction, alkylation and
precipitation steps were performed overnight. Protein pellets
were then resuspended in 8M urea/50mM Tris pH8 and their
concentrations were determined with the Qubit Protein Assay
(Invitrogen, Thermo Fisher Scientific). 10 µg of protein were
digested with LysC for 2 h at 37◦C, followed by Trypsin digestion
overnight at RT.
The digests were analyzed by liquid chromatography on a
Dionex, Ultimate 3,000 coupled to a LUMOS mass spectrometer
(Thermo Fisher Scientific) with two injections of 500 ng peptides.
The samples were loaded in random order onto a pre-column
(C18 PepMap 100, 5 µm, 100 Å, 300 µm i.d. × 5 mm
length) at a flow rate of 50 µL/min with solvent C (0.05%
TFA in water/acetonitrile 98:2). After loading, peptides were
eluted in back flush mode onto a C18 column (5 µm, 100 Å,
75 µm × 15 cm) by applying a 90-min gradient of 5 to
40% acetonitrile in water, 0.1% formic acid, at a flow rate of
400 nl/min. Data acquisition was made in data dependent mode
with precursor ion scans recorded in the orbitrap with resolution
of 120’000 (at m/z = 250) parallel to top speed fragment spectra
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of the most intense precursor ions in the linear trap for a cycle
time of 3 s maximum.
Data were processed with MaxQuant (version 1.6.14.0)
against the Homo Sapiens swissprot database (release
October 2020) using default settings for peak detection,
strict trypsin cleavage rule allowing a maximum of three missed
cleavages. Carbamidomethylation on cysteine was set as a fixed
modification, methionine oxidation and protein N-terminal
acetylation as variable modifications.
Protein intensities were reported as MaxQuant’s Label Free
Quantification (LFQ) values, as well as iTop3 (top3) values
(sum of the intensities of the three most intense peptides). For
the latter, variance stabilization (vsn) was used for the peptide
normalization, and missing peptide intensities were imputed in
the following manner: if there was at most one evidence in
the group of replicates, the missing values were drawn from
a Gaussian distribution of width 0.3 centered at the sample
distribution mean minus 2.5× the sample’s standard deviation,
otherwise the Maximum Likelihood Estimation (MLE) method
was used. Imputation at protein level for LFQ was performed
if there were at least two measured intensities in at least one
group of replicates. In this case, missing values were drawn from
a Gaussian distribution as described before if there was at most
one evidence in the replicate group, otherwise MLE was used.
Evaluation of overrepresented Gene Ontology (GO) biological
processes was performed using Panther2. To display protein
interactions, selected proteins were uploaded into String
database3. Venn diagrams were designed using the jvenn
software4.
RNA Extraction, cDNA Synthesis and
Quantitative Real-Time Polymerase
Chain Reaction (qPCR)
Total RNA was purified from cells using the innuPREP RNA Mini
kit (Analytik Jena AG, Jena, Germany) according to the standard
protocol for eukaryotic cells. RNA concentration and quality was
assessed using a Nanodrop 2000c (Thermo Fisher Scientific).
500 ng of total RNA were used as template for cDNA synthesis
with M-MLV Reverse Transcriptase and Oligo(dT)15 Primer
(both from Promega, Dübendorf, Switzerland). The analysis and
quantification of the mRNA levels were performed by qPCR
using GoTaq qPCR Master Mix (Promega) on a QuantStudio 3
instrument (Applied Biosystems, Thermo Fisher Scientific). The
1CT or the 11CT method was used for the calculation of the
mRNA expression, normalizing values of each sample to GAPDH.
qPCR primers (Supplementary Table 1) were designed with the
NCBI primer tool5 and tested for specificity and efficiency.
Lentiviral Plasmids and Virus Preparation
Lentiviruses were produced in HEK293T cells with the packaging





Trono (Addgene plasmids #12260 and 12259)). The pLentiCas9-
BFP and the pDECKO_mCherry plasmids (both gifts from
Roderic Guido & Rory Johnson (Addgene plasmids #78545 and
78534)) were used for the CRISPR knockouts, while pCAD-
IRES-GFP was applied for the rescue experiments. 24 h after cell
transfection with ViaFect (Promega) in OptiMEM, transfection
medium was replaced with Dulbecco’s modified Eagle’s medium
(DMEM) (Thermo Fisher Scientific) containing 10mM HEPES,
pH7.4 (Thermo Fisher Scientific). Virus-containing supernatants




Keratinocytes were transduced in 6-well plates by spinfection
(2,000 rpm for 90 min at 37◦C) in the presence of 5 µg/ml
polybrene (Sigma-Aldrich) with the pLentiCas9-BFP viral
supernatant. After transduction, Cas9-positive cells were selected
for with 4 µg/ml Blasticidine S hydrochloride (Sigma-Aldrich)
and sorted twice for BFP expression using the MoFlo R©
AstriosTM EQ cell sorter (Beckman Coulter Life Sciences,
Krefeld, Germany).
To target IRF6, two single guide RNAs (sgRNA)
were designed specific for IRF6 exon number 3
(5′-TGGGCTCATCTGGCTACACA-3′) and exon 4 (5′-
CCCTGACCCAGCTAAATGGA-3′), respectively, using
CRISPETa (CRISPR Paired Excision Tool) software pipeline.
The oligos were purchased from Microsynth AG (Balgach,
Switzerland) and cloned into the pDECKO_mCherry vector
using Gibson Assembly Master Mix (New England Biolabs,
Ipswich, MA, United States). Plasmid was sequence-verified
before production of the lentiviral supernatant. 5 × 104 Cas9
expressing NTERT/1 cells were seeded in 12-well plates and
transduced with lentivirus suspension (pDECKO_mCherry
containing the two IRF6 sgRNAs) diluted 1:1 in DMEM in the
presence of 5 mg/ml polybrene using spinfection. Medium was
changed 4-6 h after the transduction to KSFM containing HEPES
buffer. In contrast, OKF6/TERT2 keratinocytes were transiently
transfected with the pDECKO_mCherry plasmid containing
the two IRF6-specific guide RNAs using ViaFect (Promega).
For both approaches, mCherry-positive cells were sorted into
96-well plates as single cells, expanded, and the IRF6 knockout
was verified in the selected clones by Sanger DNA sequencing,
staining, and immunoblotting.
Crystal Violet Staining and Cell
Morphology Analysis
Morphology of single cells and of colonies was assessed by
crystal violet staining. Briefly, cells were fixed in 4% PFA for
20 min at RT, washed in PBS and stained with 0.5% crystal violet
(Sigma-Aldrich) in 20% methanol for 20 min at RT. Excessive
stain was removed by rinsing the dishes extensively with H2O
before air-drying. Representative pictures of the cell colonies were
taken using the Olympus BX-51 phase microscope (OlympusLife
Science Solutions).
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The ImageJ software was used to quantify the cell size and the
cell colony circularity. Circularity was calculated as c = 4π(A/P2).
A: area of colony; P: perimeter of colony. For a perfect circle:
c = 1. Analysis was performed blinded by two members of the
laboratory (LP and MD).
Scratch Assay
Keratinocytes were cultured until confluence. The monolayer was
scratched using a sterile 20 µl pipette tip. Cells were then washed
with PBS to remove cell debris and incubated in fresh medium
at 37◦C/5% CO2. Images of identical spots of the scratches were
captured every hour. Closure of the scratch was analyzed using
the TScratch software6.
Alternatively, we used the IncuCyte S3 (Sartorius, Göttingen,
Germany) live imaging device. Briefly, 6× 104 keratinocytes were
seeded in a 96-well ImageLockTM Microplate (Sartorius). After
reaching confluency, the monolayer was scratched with a 96-pin
Incucyte WoundMaker (Sartorius). Scratch assays were analyzed
with the Cell Migration Software Application Module (Sartorius).
Cell Growth
To determine cell growth, 104 cells/ml were seeded into 60 mm
culture dishes. After attachment, cells were trypsinized and
counted (t = 0) using a Neubauer Counting chamber and an
automated cell counter (CountessTM II, Invitrogen, Thermo
Fischer Scientific) using Trypan Blue as a viability marker.
KSFM was replaced every other day and keratinocytes counted
daily for 5 days.
In vitro Differentiation
Keratinocytes were grown in basal KSFM (0.1 mM CaCl2) for
3 days. Thereafter, 6 × 104 cells were seeded into 35 mm
culture dishes in basal KSFM. 24 h later, Ca2+ concentration was
increased to 1.2 mM to induce differentiation. 3 days after this
Ca2+-switch, total RNA and proteins were extracted and parallel
cultures were fixed.
Alternatively, we applied a cell density-dependent
differentiation assay. For that purpose, keratinocytes were
grown in fully supplemented KSFM and plated at a cell density
of 105 cells/100 mm dish. After the emergence of first colonies
(2-3 days), RNA and protein samples were extracted, and parallel
dishes fixed (low density LD). The same samples were collected
of parallel cultures at full confluence (high density HD).
3D-Skin Models
For the 3D-skin models of control and IRF6 KO keratinocytes,
the protocol from CELLnTEC (CELLnTEC advanced cell system
AG, Bern, Switzerland) was used. Briefly, 2 × 105 keratinocytes
were seeded in 400 µl KSFM into polycarbonate inserts
(0.4 µm pore size, 12 mm diameter, Nunc, Thermo Fisher
Scientific) placed in 60 mm tissue culture dishes, immediately
followed by the addition of 11 ml of KSFM outside the inserts.
Confluency was confirmed by staining one insert from each
culture with the staining kit (CnT-ST-100, CELLnTEC). In
confluent monolayer cultures, differentiation of keratinocytes
was induced by switching from KSFM to 3D Barrier Medium
6www.cse-lab.ethz.ch/software/
(CnT-PR-3D, CELLnTEC), added both inside and outside of the
insert (equal level) overnight. After 24 h, the medium inside
the insert was completely removed and the one outside of
the insert was replenished with 3.2 ml 3D Barrier Medium,
lifting the membranes to the air-liquid interface. Thereafter,
keratinocytes were incubated for 15 days at 37◦C/5% CO2 with
medium replacement 3 times per week. 3D-cultures were then
fixed in 4% PFA for 2 h at 4◦C. The polycarbonate membranes
were excised from the inserts, cut into two pieces, placed
in embedding cassettes between two biopsy pads, and stored
in 0.1 M sodium cacodylate buffer at 4◦C. Membranes were
dehydrated, paraffin embedded and sectioned on a Reichert-
Jung microtome (Leica Microsystems, Heerbrugg, Switzerland).
Paraffin sections were deparaffinized, rehydrated through xylene,
ethanol, and deionized H2O, and stained with hematoxylin and
eosin (H&E). H&E sections were analyzed and quantified using
the ImageJ software.
Immunohistochemical (IHC) staining reactions were
performed by automated staining using a BOND RX autostainer
(Leica Microsystems). Briefly, sections were deparaffinized
and antigen was retrieved using 1 mM Tris solution (pH
9.0) for 30 min at 95◦C. Sections were stained with primary
rabbit polyclonal anti-Loricrin antibody (PA5-30583; Thermo
Fisher Scientific) followed with secondary antibody, and
specific binding of primary antibodies was visualized using a
polymer-based visualizing system with horseradish peroxidase
as the enzyme and 3,3-diaminobenzidine (DAB) as a brown
chromogen (Leica Microsystems). Finally, the samples were
counterstained with hematoxylin and mounted with Aquatex
(Merck, Burlington, MA, United States).
Generation of IRF6/GRHL3
Overexpressing Cells
Full-length cDNAs encoding for human IRF6 and GRHL3 were
cloned into the lentiviral expression vector CAD-IRES-GFP by
Genescript (Leiden, Netherlands). Lentiviral supernatants and
transductions were prepared as described before. Transduced
keratinocytes were sorted for GFP expression and the population
of GFP-positive cells (pool) was used for rescue experiments.
Statistical Analysis
Experiments were performed at least three times in multiple
replicates. Data were analyzed using Prism 7.0 (GraphPad,
La Jolla, CA, United States). Data are represented as
means ± standard deviation (SD). Multiple comparisons
were performed using one- or two-way analysis of variance
(ANOVA) with Tukey’s post hoc test. Values of p ≤ 0.05 were
considered significant.
RESULTS
Higher Expression of IRF6 in Skin-
Compared to Oral Mucosa-Derived
Keratinocytes
Next to immune cells (Joly et al., 2016) and certain osteocytes
(Thompson et al., 2019), IRF6 is greatly expressed in cutaneous
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 September 2021 | Volume 9 | Article 718066
fcell-09-718066 September 28, 2021 Time: 15:28 # 6
Girousi et al. IRF6 Function in Human Keratinocytes
and oral keratinocytes (Ingraham et al., 2006; Knight et al.,
2006). We took advantage of our primary cell bank (Parisi et al.,
2021) and compared the morphology, levels of differentiation
markers, and IRF6 levels between three oral mucosa- and
three independent foreskin-derived keratinocyte populations.
Tissue-specificity of the keratinocyte cultures (at the same cell
density) was distinguishable from each other since skin-derived
keratinocyte formed coherent and round-shaped colonies
whereas the ones from oral mucosa keratinocytes appeared
polymorph and less compact, and since only skin keratinocytes
were found to display robust Keratin10 (KRT10) levels. In
regard to IRF6, we detected a significantly higher mRNA and
protein expression in the skin-derived than in the mucosa-
derived keratinocytes (Figure 1A). From one additional tissue
donor, we were able to isolate both skin- and mucosa-derived
keratinocytes. We used these cells to prove that the observed
difference in IRF6 expression between mucosal- and skin-derived
keratinocytes (Figure 1A) is not due to the variability among
tissue donors. After confirming tissue identity of the cells by
the presence or absence of robust KRT10 levels, we observed
an increased IRF6 mRNA expression in skin keratinocytes when
compared to the oral mucosa counterpart (Figure 1B). These
distinct IRF6 expression levels suggest certain tissue-specific
activities of IRF6. This prompted us to address IRF6 function
in oral mucosa and skin keratinocytes by depleting it using a
CRISPR/Cas9 approach.
We initially planned to use primary keratinocytes for
the study, but refrained from this idea as the CRISPR/Cas9
approach requires several experimental steps (transductions,
cell sorting, single cell outgrowths) that might be challenging
to perform with primary keratinocytes, which are delicate
to keep as healthy-growing (not-differentiated and not-
senescent) cells over several passages. Envisioning these caveats
when using primary keratinocytes for the CRISPR/Cas9
approach, we thought of alternative cell models reflecting the
observations made in the primary cells. Therefore, we chose
to use the well-established immortalized oral mucosal line
OKF6/TERT2 (OKF6) and the foreskin-derived N/TERT1 (N)
keratinocytes for future experiments (Dickson et al., 2000).
First, we carefully characterized these two cell lines for their
usefulness. Proteomics of the two cell lines cultured to high-
density (HD) detected 3,036 proteins shared between them
(Figure 1C). Of these common proteins, 91 were significantly
differentially expressed (log2 fold change >1; Supplementary
Figure 1 and Supplementary Table 2). These proteins mainly
belonged to biological processes related to keratinization and cell
differentiation, which confirms the mucosal- and skin-related
origin of OKF6 and N keratinocytes, respectively. IRF6 was
not included in the list of the differentially expressed proteins,
but was found to be 1.5-fold higher expressed in N than in
OKF6 keratinocytes. This was confirmed by qPCR showing
higher IRF6 mRNA expression in skin- than in in mucosa-
derived keratinocytes (Figure 1D and Supplementary Data
Sheet 2). In addition, OKF6 and N keratinocytes showed the
typical colony morphology and KRT10 expression pattern
fitting to primary cells derived from their original tissues
(Figure 1A). These observations as well as the fact that both
TERT-immortalized keratinocyte lines are very similar to
primary keratinocytes in regard to differentiation (Smits et al.,
2017) let us conclude that OKF6 and N keratinocytes proved to
be good cell models for our study.
IRF6 Knockout in OKF6/TERT2 and
N/TERT1 Keratinocytes
We applied the CRISPR/Cas9 approach to create IRF6 knockout
OKF6 and N keratinocytes (Supplementary Figure 2A). Cell
clones derived from single cells were thoroughly validated
by DNA Sanger sequencing, immunoblotting and fluorescent
staining for ablation of IRF6. Immunoblots for IRF6 confirmed
absence of IRF6 in two OKF6 clones (#15 and #26) and in
two N clones (#8 and #10), while the pool of the cells (bulk of
cells after sorting upon guide RNA transfection/transduction)
displayed strongly reduced IRF6 levels compared to their
respective parental wildtype (wt) as well as stable Cas9-
expressing cells (Supplementary Figure 2B). These results
were further verified by staining for IRF6, which showed
cytoplasmic expression of IRF6 in parental and Cas9-expressing
cells, but is completely absent in the knockout cell clones
(Supplementary Figure 2C).
Lack of IRF6 Alters Cell-Cell Adhesion
and Colony Morphology
Culturing the IRF6-deficient cells at low density (LD) revealed
subtle, but significant differences at the single cell as well
as cell colony morphology level. Proliferating OKF6 and N
keratinocytes at LD formed cohesive and compact cell colonies
with cells showing stable contacts, as assessed by live imaging,
E-Cadherin positivity at the sites of cell-cell contacts, and
crystal violet (CV) staining. In contrast, IRF6 ablation in
keratinocytes impaired their capacity to form regularly shaped
and coherent colonies (Figure 2A and Supplementary Figure 3).
While we did not observe any obvious re-arrangements of
the actin cytoskeleton (F-actin), IRF6-deficient keratinocyte
colonies acquired a more scattered morphology with less stable
expression of E-Cadherin at the cell-cell contacts. Often, single
cells appeared to break free from the colony and we also
observed an increased fraction of significantly enlarged cells in
the cultures of IRF6-depleted keratinocytes compared to control
(Figure 2A). In order to validate these observations, we analyzed
50 random pictures of CV-stained keratinocyte cultures at the
same cell density for the presence of single cells as well as
for their colony morphology (colony circularity) and single cell
size (cell area). All these parameters were significantly altered
in the IRF6 knockout clones compared to their corresponding
controls. IRF6 ablation in both OKF6 and N keratinocytes
resulted in the appearance of more single cells, a decreased colony
circularity (less round colonies), and an increased proportion
of enlarged cells (increased individual cell area) (Figure 2B).
Prompted by these observations, we wanted to learn whether
the observed cellular phenotype in the IRF6 knockout clones is
due to IRF6 depletion and whether it can be rescued by either
re-expressing IRF6 or one of its downstream targets, Grainyhead-
like transcription factor 3 (GRHL3). Ectopic expression of
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FIGURE 1 | (A) Comparison of the colony morphology, Keratin10 (KRT10) and IRF6 expression in three individual primary oral mucosa-derived keratinocytes
(Mucosa 1-3) compared to three foreskin-derived keratinocytes (Skin A-C). Note that the skin-derived cells form tightly packed colonies, express high levels of
KRT10, and express more IRF6 than mucosa-derived cells. ∗p < 0.05 (IRF6 and KRT10 levels in Skin vs. Mucosa). Scale bar: 100 µm. kDa: kilo Dalton. (B) KRT10
and IRF6 mRNA levels of mucosal- and skin-derived keratinocytes from the same donor show higher expression of both genes in the skin. ∗p < 0.05 (KRT10 and
IRF6 levels in Skin vs. Mucosa). (C) Venn diagram of the proteomic analysis comparing OKF6/TERT2 (oral mucosa) and N/TERT1 (foreskin) keratinocytes reveals a
high number of proteins present in both cell lines, 189 and 159 proteins are unique to OKF6/TERT2 and N/TERT1, respectively. From the 3,036 shared proteins, 91
proteins are differentially expressed (>2 fold) and mostly associated with the biological processes of epidermal differentiation, keratinization, and cornification (table
right). (D) Similar to the observations in primary keratinocytes, N/TERT1 keratinocytes form more cohesive and regularly shaped colonies and express higher levels of
KRT10 and IRF6 than the oral mucosa-derived OKF6/TERT2. Scale bar: 100 µm. ∗p < 0.05 (KRT10 levels in Skin vs. Mucosa); ∗p < 0.05 (IRF6 levels in Skin vs.
Mucosa). Full-length immunoblots are shown in Supplementary Figure 9.
IRF6 in IRF6-deficient cells resulted in strongly increased IRF6
mRNA levels in both cell lines (Supplementary Figure 4A),
but only to a robust overexpression of the IRF6 protein in
OKF6 cells, with IRF6 remaining ablated in N IRF6-deficient
cells (Figure 2C). This difference was due to the fact that the
OKF6/Cas9 keratinocytes were transiently transfected with the
IRF6-specific guide RNAs-containing vector, in contrast to its
stable transduction into N/Cas9 keratinocytes (see Materials and
Methods). In contrast, forced GRHL3 expression resulted in
elevated GRHL3 mRNA and protein levels in both cell lines
(Figure 2C and Supplementary Figure 4A). The phenotype
of scattered cells and dispersed cell colonies in IRF6-deficient
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keratinocytes could be rescued by strong ectopic IRF6 in OKF6
clones, as these cells started to form cohesive colonies again.
However, low IRF6 in N/TERT IRF6 knockout clones could not
normalize the cell and colony morphology as assessed by live
imaging and crystal violet staining (Figure 2D). GRHL3 may not
have a role in colony morphology (Supplementary Figure 4B)
but the effect of its overexpression in IRF6-deficient keratinocytes
will be described later.
IRF6-Deficient Keratinocytes Maintain
Their Epithelial Character
Both the increased cell size and the appearance of more scattered
and single cells are phenotypes that have been associated
with epithelial-mesenchymal transition (EMT; (Lamouille and
Derynck, 2007). This prompted us to test whether lack of IRF6
induces an EMT. IRF6-deficient keratinocytes showed a slight
tendency of increased mRNA levels of the mesenchymal markers
Fibronectin (FN), Vimentin (VIM), and Snail (SNAIL), while
the epithelial markers GRHL3 and IRF6 were downregulated
compared to the corresponding controls (Figure 3A). Notably,
reduced IRF6 mRNA levels are probably the results of either
diminished stability of the altered transcripts or due to the
missing IRF6 self-regulation (Botti et al., 2011) in IRF6-
deficient cells. E-Cadherin (CDH1), one of the most prominent
epithelial markers was not affected in response to IRF6 depletion
(Figure 3A). Identical E-Cadherin levels, as well as altered
levels of FN in the clones were confirmed by immunoblotting
(Figure 3B). Although these results indicate that IRF6-defcient
keratinocytes maintain their epithelial character, they were not
conclusive yet in elucidating the role of IRF6 in the EMT
process. Therefore, we triggered an EMT by treating N control
and clone #10 keratinocytes with transforming growth factor β1
(TGFβ1), TGFβ3, and epidermal growth factor (EGF), which are
known EMT inducing factors (Lamouille et al., 2014). Treatment
of the control cells resulted in enlarged and more scattered
cells, similar to the morphology of IRF6-deficient keratinocytes
(Figures 3C,D) and in a robust and significant increase of
the mesenchymal markers FN, VIM and SNAIL, suggestive of
mesenchymal cell characteristics (Figure 3E). While TGFβ1 was
not able to alter the levels of the epithelial markers GRHL3
and CDH1, it triggered a significant increase of IRF6 in control
keratinocytes. This observation in combination with the fact
that the induction of all mesenchymal markers was significantly
impaired in the absence of IRF6 (clone #10) when compared to
control suggests an important role for IRF6 as mediator during
the regulation of EMT (Figure 3E) as it has been described in
mice (Ke et al., 2015).
IRF6 Is Required for Coordinated
Movement of the Keratinocytes
Irf6 has been described as a transcription factor regulating wound
healing and keratinocyte migration in mice (Biggs et al., 2014).
Therefore, we wanted to assess IRF6 function in regulating
migration of human postnatal keratinocytes. Lack of IRF6 in
both oral mucosa- and skin-derived keratinocytes delayed the
closing of an in vitro scratch (Figures 4A,B). These observations
were confirmed by live imaging using the Incucyte Scratch
Wound Assay R© and its automated analysis (Figure 4C). These
analyses allowed us to realize that next to a delay in wound
closure, the IRF6-deficient keratinocytes also differed in their
pattern of migration compared to their respective controls.
While the keratinocytes of both control cell lines, OKF6 and N,
consistently moved as continuous epithelial sheets in a directed
migration pattern, with leading edge keratinocyte in front of
follower cells, IRF6-deficient keratinocytes moved preferentially
as single cells, with random and undirected migration paths.
Therefore, increased presence of single cells in the scratch
compared to controls was a prominent hallmark of IRF6-deficient
keratinocytes (Figure 4D, arrowheads). This observation is
reminiscent of the morphological differences observed earlier
(Figures 2A,B).
IRF6 Is Required for the Expression and
Induction of Early and Late
Differentiation Markers
Since IRF6 is a master regulator of the balance between
keratinocyte proliferation and differentiation (Richardson et al.,
2006), we wished to analyze the proliferation rate of human
postnatal keratinocytes in the absence of IRF6. Cell growth
as well as qPCR analyses for the proliferation markers
Proliferating-Cell-Nuclear-Antigen (PCNA) and Ki67 at both LD
and HD cultures did not disclose any significant differences
between IRF6 knockout keratinocytes and their controls
(Supplementary Figure 5).
Next, we assessed the differentiation potential of human
keratinocytes in the absence of IRF6. Addition of exogenous
Ca2+ to keratinocytes grown in basal growth medium induced
differentiation after three days in both OKF6 and N control
keratinocytes. They started to form dense colonies with signs
of stratification in the center (Figure 5A, asterisks), and
elongated cells at the margins (Figure 5A, arrowhead). In
contrast, the IRF6-deficient keratinocytes, while also changing
their morphology in response to Ca2+, did not show any
signs of differentiation as described before (Figure 5A). To
detect changes in the transcriptome in non-confluent cultures
after the Ca2+-switch, we performed qPCR analyses for a
panel of typical differentiation markers of skin- and mucosa-
derived keratinocytes (Figure 5B). The Ca2+-switch triggered
a robust induction of the early and late differentiation markers
Transglutaminase 1 (TGM1), Involucrin (IVL), Keratin13
(KRT13), IRF6, and GRHL3 in OKF6 control keratinocytes,
and of KRT10, TGM1, IVL, Filaggrin (FLG), Loricrin (LOR),
IRF6, and GRHL3 in N control keratinocytes (Figures 5B,C).
In contrast, IRF6-ablated keratinocytes showed an impaired
differentiation capacity as none of these markers were induced
in response to Ca2+ (Figures 5B,C). Notably, levels of some
of these markers, such as TGM1, were already diminished
in the knockout keratinocytes when compared to controls
in the basal conditions, suggesting an important role of
IRF6 for their regulation (Figure 5B). These results were
further confirmed at protein level by staining OKF6 for
IVL and TGM1, and N for IVL and LOR in controls
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FIGURE 2 | (A) In the absence of IRF6, OKF6/TERT2 and N/TERT1 keratinocytes change their colony morphology as assessed by live imaging, F-actin (phalloidin,
red), E-Cadherin (green), and crystal violet (CV) staining. DAPI was used to stain for nuclei (blue). Scale bars: 20 µm (Live Imaging); 150 µm (F-Actin, E-Cadherin);
100 µm (CV). (B) IRF6 knockout in both OKF6/TERT2 and N/TERT1 cell lines results in significantly more single cells (sc), reduced colony circularity (cc) as well as in
the emergence of larger single cells (cell area) when compared to their respective controls. ∗p < 0.05 controls vs. clones (sc); ∗p < 0.05 controls vs. clones (cc, cell
area). (C) Immunoblots show overexpression of IRF6 and GRHL3 in the IRF6-deficient keratinocyte clones after transduction. Note the very little expression of
ectopic IRF6 in N/TERT1 IRF6 knockout clones. kDa: kilo Dalton; ex.: exogenous. (D) Live imaging and crystal violet pictures of typical colony morphologies upon
re-expression of IRF6 in the IRF6 K.O. clones. Note that low IRF6 levels are not able to rescue the dispersed colony phenotype. Scale bar: 100 µm. Full-length
immunoblots are shown in Supplementary Figure 9.
and their corresponding IRF6 knockout clones at 1.2 mM
Ca2+ (Figure 5D).
In addition, we subjected the IRF6 knockout keratinocytes
to another, cell density-dependent in vitro differentiation
assay (Poumay and Pittelkow, 1995). Specifically, we analyzed
and compared both the cell morphology and the levels of
differentiation markers in LD and HD cultures. At HD, both
control cultures differentiated with enlarged cells emerging on
top of the monolayer (Supplementary Figure 6A, arrowheads),
while differentiation was impaired in the absence of IRF6.
Analyses of various differentiation markers by qPCR, staining,
and immunoblotting confirmed severe differentiation defects
in IRF6-deficient keratinocytes (Supplementary Figures 6B-E).
Impaired differentiation at HD in the absence of IRF6 could
be at least partially rescued by ectopic expression of IRF6 and
GRHL3, as assessed by increased levels of IVL and TGM1
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FIGURE 3 | (A) qPCR analyses for the epithelial markers CDH1, GRHL3, and IRF6 as well as for the mesenchymal markers FN, VIM, and SNAIL in OKF6/TERT2
(left) and N/TERT1 (right) cell lines. Note that although there is a slight increase of the mesenchymal markers, CDH1 does not decrease in the absence of IRF6. ctrl.:
control; ∗p < 0.05 controls vs. clones #15, #26, #8, #10. (B) Immunoblots confirm the qPCR results and show no change in E-Cadherin, but an increase in FN, and
absence of IRF6 in the clones. kDa: kilo Dalton; ctrl.: control. (C) Treatment of N/TERT1 controls (top row) with the EMT-inducing growth factors EGF, TGFβ1, and
TGFβ3 for 72 h induces changes in the cellular morphology with scattered and enlarged cells (arrowheads). In N/TERT1 clone #10 (bottom row) a similar
morphological phenotype can already be appreciated without addition of growth factors. ∗ indicates enlarged cells. Scale bar: 150 µm. (D) Crystal violet staining and
cell area analysis of N/TERT1 control in the absence and presence of TGFβ1 (72 h) reveals the emergence of enlarged cells in the presence of the growth factor.
∗p < 0.05 control vs. TGFβ1-treated cells; ctrl.: control. (E) qPCR analyses for the mesenchymal markers FN, VIM, and SNAIL as well as the epithelial markers
CDH1, IRF6, and GRHL3 in TGFβ1-treated (72 h) cells in the presence (control) or absence (clone #10) of IRF6. Note that the mesenchymal markers as well as IRF6
increase, while CDH1 does not change. Also note that IRF6 is required for a proper modulation of all these markers. #p < 0.05 untreated vs. TGFβ1-treated cells;
∗p < 0.05 control vs. IRF6 knockout cells (clone #10). Full-length immunoblots are shown in Supplementary Figure 9.
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FIGURE 4 | (A) Live Imaging pictures of the in vitro scratch at the indicated times after wounding the confluent monolayer and before scratching. Left side:
OKF6/TERT2; Right side: N/TERT1. Scale bar: 500 µm. (B) Quantification of the manual scratch shows a delay of the wound closure in the absence of IRF6.
∗p < 0.05 control vs. clones. (C) Quantification of an automated live imaging scratch assay confirms impaired closure of the scratch in the IRF6 knockout
keratinocytes compared to control. ∗p < 0.05 control vs. clones. (D) Pictures of N/TERT1 control and N/TERT1 clone #10 taken at the time of scratching (0 h), 5 h,
and 10 h shows that lack of IRF6 results in significantly more cells that move randomly as single cells (arrowheads, right side) compared to control (left side).
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(Supplementary Figure 7). Low levels of exogenous IRF6 in
clone #8 (N cells) (Figure 2C) were not able to induce IVL and
TGM1 expression, suggesting that a certain IRF6 threshold is
required for its proper function.
These differentiation defects in 2D inspired us to use N
keratinocytes for the establishment of 3D organotypic skin
cultures in the absence or presence of IRF6. H&E staining
of such 3D cultures revealed that while control keratinocytes
were able to fully differentiate with the appearance of the
typical cell layers, IRF6-deficient keratinocytes failed to build
a healthy epidermis (Figure 6A). Although N keratinocytes
were able to form a stratum granulosum (SG) and signs of
a stratum corneum (SC) even in the absence of IRF6, these
two cell layers were clearly not properly developed in IRF6-
deficient cells compared to control cells. Immunohistochemical
staining for the late differentiation marker LOR confirmed these
observations as it was strongly and specifically expressed in
the SG in control organotypic cultures. Strikingly, patchy areas
of weakly LOR-positive cells were observed in the absence of
IRF6 (Figure 6B). We quantified the morphological defects and
measured a significantly diminished area of the two outermost
layers (stratum lucidum (SL) and SC) as well as a reduced
area with granulated, LOR-positive keratinocytes in the SG
(Figure 6C, left and middle) in the absence of IRF6. Additionally,
we observed the presence of cell nuclei in the two outermost
layers when IRF6 was lacking, which is in stark contrast to
controls (Figure 6C, right, arrowheads) and further confirms
lack of a properly cornified layer on top of the IRF6-deficient
epidermis in 3D-skin models.
Proteomics Reveal Skin Homeostasis,
Immune Response, and ECM as Major
Protein Clusters Affected by the Lack of
IRF6
To learn more about IRF6 function in both skin and oral mucosa,
the proteomes of IRF6-deficient OKF6 and N cells were analyzed
and compared to their corresponding controls. A total of roughly
3,200 proteins were identified (Supplementary Data Sheet 2
and Supplementary Figure 8). Normalized heat maps as well
as hierarchical clustering revealed different proteomic profiles
between OKF6/TERT2 and N/TERT1, and between their IRF6
knockout clones (Figure 7A). Employing strict criteria for the
analysis (log2 fold change >1 (except for FN, which we confirmed
by immunoblotting), we determined roughly 70 differentially
expressed proteins in N control compared to IRF6 knockout
clones (Supplementary Table 3) and only about 20 proteins
for OKF6 (Supplementary Table 4). A selection of differentially
expressed proteins could be categorized to the main functional
groups “Skin Homeostasis,” “Immune response/IFN-related”,
and “ECM” in both the cell lines (Figure 7B,C). To further
identify protein clusters among the differentially expressed
proteins and their putative biological functions, these proteins
were inserted into the STRING database for potential networks.
STRING networks were retrieved indicating the main protein
clusters affected by the lack of IRF6 (Figures 7B,C): Immune
response/IFN-related (green), Skin Homeostasis (yellow), and
ECM (red). We verified a panel of the identified proteins by
analyzing their transcript levels. qPCR analyses for the genes
Galectin-7 (GAL7), S100A8, S100A9, Desmoglein-1 (DSG1), and
Desmocollin-2 (DSC2) showed that lack of IRF6 significantly
decreased all their transcript levels (Figure 7D). In conclusion,
our data show that IRF6 plays an important role in the
regulation of skin homeostasis and keratinocyte-effected immune
response in both oral mucosa- and skin-derived postnatal
human keratinocytes.
DISCUSSION
Most of our knowledge on IRF6 has been gained from animal
models and murine cells. Yet, studying IRF6 in human cells
is important since IRF6 variants are associated with non-
syndromic CLP cases as well as causative for two syndromic
forms of orofacial clefting, VWS and PPS (Kondo et al., 2002).
In addition, IRF6 has been found mutated in head and neck
squamous cell carcinoma (Stransky et al., 2011) and IRF6 is
often lost or downregulated in many solid cancers (Bailey
et al., 2008; Botti et al., 2011). Still, complete and detailed
knowledge on IRF6 function, its upstream and downstream
effectors in human postnatal keratinocytes remains elusive. Our
study on IRF6 function in postnatal human keratinocytes mostly
confirms and complements the various studies using embryonic
murine Irf6−/− keratinocytes (Biggs et al., 2012, 2014; Rhea
et al., 2020). The two most apparent defects in IRF6-ablated
keratinocytes were phenotypes related to cell morphology and to
epidermal homeostasis.
We applied two distinct in vitro differentiation assays
to assess the differentiation potential of human skin- and
oral mucosa-derived keratinocytes in the absence of IRF6.
In both cell lines, disruption of IRF6 impaired the entire
epidermal differentiation program. The early (e.g., KRT10) as
well as late (e.g., LOR) differentiation markers were deregulated
in IRF6-deficient keratinocytes compared to their controls
under differentiating conditions (Figure 5 and Supplementary
Figure 6). We also noted some variations between the two
in vitro differentiation assays. While the Ca2+-switch did not
induce any of the differentiation markers in both cell lines in
the absence of IRF6, the cell density-dependent differentiation
triggered an induction of some of the markers, whose levels
however remained significantly lower than in the control. We
conclude that IRF6 is important for regulating early as well
as late differentiation events in both oral mucosa and skin. In
agreement with this observation, 3D organotypic skin models
indicated that IRF6 knockout keratinocytes failed to build a
healthy and regular epidermis. The SG as well as the SC appeared
inadequately formed in the absence of IRF6, as both were
significantly thinner compared to the ones built in controls.
Furthermore, the SG did not develop properly, but rather patchy,
which was confirmed by staining for LOR (Figures 6B,C).
LOR levels were significantly decreased compared to control,
and only a small fraction of keratinocytes displayed a highly
heterogenous positivity. Also, abnormal presence of nucleated
cells in the stratum corneum, a phenotype originally described
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FIGURE 5 | (A) Live Imaging pictures and F-actin staining (phalloidin, red) with or without (only Live Imaging) exogenous Ca2+ addition. While the control
keratinocytes start to differentiate (asterisk and arrowheads), lack of IRF6 impairs differentiation. Scale bar: 200 µm (Live Imaging); Scale bar: 150 µm (F-actin).
(B) Heatmaps of the qPCR analyses of various differentiation markers in basal (0.1 mM) vs. high Ca2+ (1.2 mM) conditions. Note that in the absence of IRF6 all the
differentiation markers are not induced upon the Ca2+-switch. n.d.: not detectable (Ct > 32); ctrl.: control. (C) qPCR analyses of specific differentiation markers
showing the lack of induction upon the addition of Ca2+ in the IRF6 knockout clones compared to controls. ∗p < 0.05 basal vs. 1.2 mM Ca2+. ctrl.: control.
(D) Immunofluorescent staining for the markers Involucrin (IVL, green) and Transglutaminase 1 (TGM1, green) in OKF6/TERT2 cells and for IVL (green) and Loricrin
(LOR, green) in N/TERT1 keratinocytes. Note that all differentiation markers were robustly induced in the control cells in the presence of IRF6. Scale bar: 50 µm.
DAPI was used to counterstain the cell nuclei (blue).
as parakeratosis (Cardoso et al., 2017), was often observed
in the absence of IRF6. Similar traits have been reported in
receptor-interacting protein kinase 4 (Ripk4)-deficient mice.
Such mice exhibit patchy areas of LOR-positive corneocytes and
nucleated cells in the outermost epidermal layer (De Groote
et al., 2015), highlighting a role for the described RIPK4-IRF6
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FIGURE 6 | (A) H&E staining of 3D skin organotypic cultures obtained with N/TERT1 control and N/TERT1 clones #8 and #10 keratinocytes. The various skin layers
are indicated. SB: stratum basale; SS: stratum spinosum; SG: stratum granulosum; SL: stratum lucidum; SC: stratum corneum. Scale bar: 100 µm. (B) Loricrin is
strongly expressed in organotypic cultures of control keratinocytes in the stratum granulosum. In contrast, Loricrin is only weakly and irregularly expressed in the
absence of IRF6. Close-up images are shown to the right of each organotypic culture. Arrowheads indicate aberrant presence of nuclei in the SC. (C) Quantification
of H&E pictures of the 3D skin models. Note that in the absence of IRF6 the area of the SL + SC (orange area left panel), as well as the SG (orange area middle
panel) are significantly reduced. Also, absence of IRF6 results in the presence of cell nuclei (arrowhead) in the SL and SC, which is not the case for control (right
panel). ∗p < 0.05 control vs. clones #8 and #10.
connection in epidermal integrity (Kwa et al., 2015; Oberbeck
et al., 2019). Strikingly, Irf6 null embryos display an expanded
spinous layer and complete lack of the stratum granulosum
and corneum (Ingraham et al., 2006). Similarly, embryonic
murine Irf6−/− keratinocytes are not competent to undergo
terminal differentiation in vitro, but Irf6 was not necessary
for Krt10 induction (Biggs et al., 2012). In contrast, our data
reveal that IRF6 is already essential for KRT10 induction and
that an irregular, probable dysfunctional SC is still formed
in the absence of IRF6. These discrepancies might be either
related to differences between mice and humans or to the fact
that embryonic is compared to postnatal tissue. In human,
it has been shown that IRF6-associated VWS patients exhibit
increased keratinocyte proliferation, but normal KRT10 levels
when compared to non-syndromic CLP cases (Hixon et al.,
2017). This suggests that even reduced IRF6 levels, as often
is the case in VWS patients (Degen et al., 2020), still are
sufficient to properly regulate KRT10 expression. Following
this idea, we provide evidence that forced expression of
IRF6 in the IRF6-deficient keratinocytes is capable of partially
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FIGURE 7 | (A) Heat map of hierarchical clustering after imputation and color key represent the total amount of identified proteins in N/TERT1 (left side) and
OKF6/TERT2 samples (right side). Note the hierarchical clusters on top demonstrating significant changes in the proteome between skin- and oral mucosa-derived
cell lines. (B) Differentially expressed proteins in OKF6 clone #26 vs. OKF6 control in cultures at high cell density (HD). Tables on the top summarize the main three
protein clusters: immune response/IFN-related (green), Skin Homeostasis (yellow), and ECM (red). String network depicting all differentially expressed proteins is
shown as well with the three main clusters as described before. Note that only proteins are shown having a differential expression of at least log2 fold change = 1.
ECM: extracellular matrix. (C) Differentially expressed proteins in N clone #10 vs. N control in cultures at high cell density (HD). Tables on the left summarize the main
three protein clusters: immune response/IFN-related (green), Skin Homeostasis (yellow), and ECM (red). String network depicting all differentially expressed proteins
is shown as well with the three main clusters as described before. Note that only proteins are shown having a differential expression of at least log2 fold change = 1.
ECM: extracellular matrix. (D) qPCR verifications for some mRNA transcripts (GAL7, S100A8, S100A9, DSG1, and DSC2) for which the corresponding proteins have
been found to be differentially expressed in both OKF6 and N cells compared to the corresponding IRF6-deficient keratinocytes. ∗p < 0.05 controls vs. clones #15
and #26, and clones #8 and #10.
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rescuing the morphological and differentiation phenotypes, but
only, if a certain IRF6 threshold is attained (Figure 2C and
Supplementary Figure 7). Such observations have already been
reported in studies using IRF6−/− embryos (Kousa et al., 2017)
and Irf6+/− mice (Rhea et al., 2020). In addition, we show
that GRHL3, a downstream target of IRF6, is able to partially
rescue the differentiation defect in IRF6-depleted keratinocytes,
which fits with the literature (de la Garza et al., 2013). However,
exogenous GRHL3 was not capable of rescuing the scattered
cell colony morphology (Supplementary Figure 4B). GRHL3
and IRF6 are transcription factors expressed in the periderm
during embryogenesis (Richardson et al., 2009; Peyrard-Janvid
et al., 2014; Richardson et al., 2014), regulate keratinocyte
differentiation (Ting et al., 2005), and are associated with CLP
and VWS (Kondo et al., 2002; de la Garza et al., 2013; Peyrard-
Janvid et al., 2014; Mangold et al., 2016). How they work together
to dictate keratinocyte differentiation is not fully elucidated
yet and needs more detailed investigations. Our data suggest a
common function during differentiation, but an IRF6-specific
activity controlling cell morphology.
Lack of epidermal integrity in the absence of IRF6 was
already visible in the stratum basale in the 3D organotypic
cultures, which was irregular and disordered (Figure 6A).
This observation fits to the second major phenotype in IRF6-
depleted keratinocytes: The appearance of altered cell size and
colony morphology. Cell colonies of IRF6-depleted cells appeared
scattered (reduced colony circularity) with less stable cell-cell
contacts and there was a significantly increased number of single
and enlarged cells in these cultures when compared to control
(Figure 2). This phenotype was more pronounced in the skin-
derived keratinocytes, which might reflect our observation that
IRF6 levels are higher in skin- than in oral mucosa-derived
keratinocytes (Figure 1). Single cells trying to evade the stable
cell colonies and increased cell size are features associated
with an EMT (Lamouille and Derynck, 2007). Although IRF6-
deficient keratinocytes displayed slightly increased levels of some
mesenchymal markers (e.g., Fibronectin), E-Cadherin levels
remained unchanged, and the growth factor-triggered EMT was
less pronounced when compared to controls (Figure 3). In
addition, EMT induction by TGFβ1 resulted in increased levels of
IRF6, which is identical to the response of Irf6 to TGFβ3 in mice
(Ke et al., 2015). This observation might be unexpected as IRF6
is described as an epithelial marker. However, it is clear that IRF6
is not a strict epithelial marker as it is also expressed in immune
cells (Joly et al., 2016) and involved in osteoblast differentiation
of craniofacial bone (Thompson et al., 2019). Furthermore, it has
been shown that ectopic Irf6 expression enhances Snai2 mRNA
levels in mice (Ke et al., 2015), which consequently leads to
the repression of Cdh1. A very recent study reports that IRF6
is responsible for the regulation of E-Cadherin to the plasma
membrane, which is important for the maintenance of cohesion
between epithelial cells (Antiguas et al., 2021). All these data
imply that EMT is partially dependent on IRF6, which is in
agreement with a previous in vivo study in mice (Ke et al., 2015),
and that epithelial cell characteristics are maintained, even in the
absence of the epithelial-specific transcription factor IRF6.
Further support in this regard was obtained from the
observation that the closure of an in vitro scratch was delayed
in the absence of IRF6 (Figure 4). Such a result is not conform
with a more detached migratory state of mesenchymal cells.
Notably, IRF6-depleted keratinocytes not only closed the wound
slower, but they also moved in a different migration pattern when
compared to control. Instead of moving as a continuous epithelial
cell sheet to close the artificial wound like control keratinocytes,
IRF6-deficient cells preferentially moved as single cells. This
observation is reminiscent of the morphological phenotypes
described above and complements previous studies using
embryonic Irf6−/− keratinocytes showing reduced migration
speed and less directionality (Biggs et al., 2014). Whether this
irregular migration pattern in vitro provides the molecular
rationale for the observed wound healing complications observed
in VWS patients in vivo remains to be elucidated and needs
additional investigations. Our data point toward a crucial role
for IRF6 in regulating intrinsic postnatal cellular characteristics
and processes. However, cell growth was not affected by
IRF6 in both OKF6 and N keratinocytes (Supplementary
Figure 5). Although similar results were obtained in mice,
Irf6 knockout attenuated the long-term proliferative potential
of the cells (Biggs et al., 2012). We refrained from such
long-term experiments, since we used TERT immortalized
cells potentially masking any effect on cell proliferation by
the absence IRF6.
Proteomics of differentiated keratinocytes confirmed our
in vitro differentiation data. Most of the differentiation markers
(e.g., KRT10, TGM1, KRT13, IVL) were downregulated in
the absence of IRF6 in both cell lines compared to control
(Figure 7). Unfortunately, LOR and FLG were not detected in
our proteomic analysis for technical reasons. Several candidate
proteins that might explain the morphological phenotypes
observed in IRF6-deficient keratinocytes were identified as
well. Among them were Desmocollin-2 (DSC2), Desmoglein-1
(DSG1), and Galectin-7 (LGALS7), which were all significantly
reduced in the absence of IRF6 (Figure 7). DSC2 and DSG1 are
components of desmosomes (Garrod and Chidgey, 2008), which
represent intercellular junctions essential for mediating cohesion,
epidermal integrity, and MAPK/ERK signaling regulation (Green
et al., 2010; Harmon et al., 2013). Disruption of desmosomes
has been attributed with loss of cell-cell contacts, EMT, impaired
skin differentiation, and lack of epidermal barrier formation
(Johnson et al., 2014). Whether IRF6-deficient keratinocytes
completely lose their desmosomes or whether only certain of
their components are altered remains to be discovered. It is
worth mentioning that in the Irf6−/− mice, desmosomes were
observed throughout the epidermis including the most superficial
keratinocyte layers in contrast to wt animals lacking desmosomes
in the superficial layers (Ingraham et al., 2006). Another
study confirmed that Irf6 knockout murine keratinocytes did
not affect the regulation of the components of desmosomes
(Ferone et al., 2013). Two proteins, RAB25 and SULT2B2,
which are known to be associated with healthy skin and
the regulation of epidermal differentiation and proliferation,
have also been found to be robustly decreased in the absence
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of IRF6 in skin-derived keratinocytes (Heinz et al., 2017;
Jeong et al., 2019).
LGALS7 is a protein belonging to a family of soluble
lectins and shows preferential expression in stratified epithelia,
including the skin and oral cavity (Magnaldo et al., 1998),
where it has crucial functions for skin homeostasis in response
to major challenges, and for the regulation of keratinocyte
proliferation and differentiation (Gendronneau et al., 2008;
Chen et al., 2016). Strikingly, LGALS7 also controls re-
epithelialization of wounds by regulating directionality,
collective cell behavior, and intercellular E-Cadherin-
dependent adhesions (Cao et al., 2003; Advedissian et al.,
2017). Proteomics also identified up-regulation of the
extracellular matrix protein Fibronectin (FN), which is
involved in various cellular aspects, for instance wound
healing (Pankov and Yamada, 2002). Nothing is known
yet about an IRF6-FN connection, which might suggest
an important role for IRF6 in epithelial-mesenchymal
interactions and might explain the maturation defect of
the granulation tissue observed during wound healing in
heterozygous Irf6+/− mice (Rhea et al., 2020). In general,
proteomics exposed more changes upon IRF6 depletion
in the skin-derived N/TERT1 keratinocytes compared to
the oral mucosal OKF6/TERT2. This might reflect our
observations that IRF6 is higher expressed in skin than in
oral mucosa (Figure 1), a tissue that lacks the outermost
cornified skin layers.
Skin integrity is achieved by formation of a properly
built skin barrier and by the adequate communication with
immune cells, including the release of cytokines and chemokines.
Both processes protect us from various external insults and
guarantee the maintenance of physiological skin homeostasis.
Using human postnatal keratinocytes we demonstrate that both
crucial functions of the skin are affected by the absence of
IRF6. Our experimental data reveal major functions for IRF6
in the differentiation program as well as in the regulation
of cell-cell contacts. Moreover, we also show that many
“immune response/IFN-related” proteins are altered in the
absence of IRF6. While a lot of knowledge has been gained
in the recent years about the function of IRF6 during various
aspects of craniofacial development, a complete understanding
of the transcription factor is still missing. Especially in
postnatal human tissues, knowledge about IRF6 remains sparse.
One limitation of our study is the use of immortalized
keratinocytes for elucidating the role of IRF6 in human cells.
While all our data using two cell lines are in line with
the literature on Irf6 function in mice, more investigations
are warranted to better understand IRF6 in primary human
cells and tissues.
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